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Abstract
In recent years, several types of pulmonary pathology, including alveolar proteinosis, fibrosis, and 
emphysema, have been reported in workers in the indium industry. To date, there remains no clear 
understanding of the underlying mechanism(s). Pulmonary toxicity studies in rats and mice have 
demonstrated the development of mediastinal lymph node hyperplasia and granulomas of 
mediastinal lymph nodes and bronchus-associated lymphoid tissues following exposure to indium 
tin oxide. Given the association between exposure to other metals and the development of 
immune-mediated diseases, these studies were undertaken to begin to investigate the immuno-
modulatory potential of unsintered indium tin oxide (uITO) in a mouse model. Using 
modifications of the local lymph node assay, BALB/c mice (five animals/group) were exposed 
topically via intact or breached skin or injected intradermally at the base of the ear pinnae with 
either vehicle or increasing concentrations 2.5–10% uITO (90:10 indium oxide/tin oxide, particle 
size <50 nm). Dose-responsive increases in lymphocyte proliferation were observed with a 
calculated EC3 of 4.7% for the intact skin study. Phenotypic analysis of draining lymph node cells 
following intradermal injection with 5% uITO yielded a profile consistent with a T-cell-mediated 
response. These studies demonstrate the potential for uITO to induce sensitization and using 
lymphocyte proliferation as a biomarker of exposure, and demonstrate the potential for uITO to 
penetrate both intact and breached skin.
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Introduction
Numerous metals are known to induce hypersensitivity responses resulting in dermal, 
respiratory, and systemic diseases (Table 1). Occupational exposure to these metals results 
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in varying levels of morbidity and mortality from chronic allergic contact dermatitis to 
potentially fatal pulmonary disease or anaphylaxis. Recently, attention has been drawn to the 
occurrence of a rare pulmonary disease, characterized by severe alveolar proteinosis, seen in 
workers exposed to indium-tin oxide (ITO). Indium is a rare metal recovered for commercial 
use via extraction from other mined metals, most often zinc. It is refined primarily in China, 
Japan, the Republic of Korea, and Canada (POLINARES, 2012). The predominant use of 
indium is in the production of ITO. Because of its electrical conductive properties, thin-film 
coatings of ITO have historically been used in the production of solar panels, solders, alloys, 
and semiconductors. More recently, ITO usage has increased with the popularity of touch-
screen computer and liquid crystal display technologies, which also use the electrically 
conductive and light transparent ITO coatings (U.S. Geological Survey, 2013). Potential 
worker exposure to indium and indium compounds occurs during mining, production, and 
reclamation processes.
In addition to pulmonary alveolar proteinosis, other pathologies including pulmonary 
fibrosis, emphysema, and granulomas with associated cholesterol clefts have been diagnosed 
in indiumexposed workers in the US, China, and Japan (Cummings et. al., 2012). Although 
a possible mechanism related to autoimmuneinduced dysfunction of macrophages has been 
proposed (Cummings et al., 2010), the pathophysiology and natural history of indium-
induced pulmonary disease(s) have not been elucidated. Given the potential of other metals 
to induce hypersensitivity responses and the lack of a complete understanding of the 
pathophysiology of the observed pulmonary disease in ITO-exposed workers, these animal 
studies were undertaken to evaluate the potential of unsintered ITO (uITO) to induce 
immune stimulation.
Materials and methods
Animals
Female BALB/c mice were purchased from Taconic Farms (Germantown, NY) at 6–8 
weeks-of-age and were allowed to acclimate for a minimum of 5 days before they were 
randomly assigned to treatment groups. Animals were weighed and individually identified 
via tail markings using a permanent marker, and an analysis of variance on body weights 
was performed to ensure homogeneous distribution of animals across treatment groups. 
Mice were housed five per cage in ventilated plastic shoebox cages with hardwood chip 
bedding, and provided ad libitum access to NIH-31 modified 6% irradiated rodent diet 
(Harlan Teklad, Frederick, MD) and tap water from water bottles. The temperature in the 
animal facility was maintained at 68–72°F and the relative humidity at 36–57%. The light/
dark cycle was maintained on 12 h intervals. All animal experiments were performed in the 
Association for Assessment and Accreditation of Laboratory Animal Care International 
accredited National Institute for Occupational Safety and Health animal facility in 
accordance with an animal protocol approved by the Institutional Animal Care and Use 
Committee.
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Chemicals
Unsintered indium tin oxide, < 50 nm (CAS# 50926-11-9), vehicles including dimethyl 
sulfoxide (DMSO, CAS # 67-68-5) and USP grade phosphate-buffered saline (PBS, pH 7.4), 
as well as a-hexylcinnamaldehyde (HCA, CAS# 101-86-0) positive control were purchased 
from Sigma Aldrich (St. Louis, MO).
Toxicity study
An initial toxicity study was conducted to determine the test article concentrations to be 
used in the subsequent studies. Three animals were exposed topically to 10% uITO that was 
chosen based on the highest concentration that remained in suspension following 10 min of 
sonication. To increase bioavailability, each day before dosing and following cleaning the 
ear with 70% ethanol, the dorsal aspect of each ear pinna was breached using a Multi-Test II 
device (manufactured by Lincoln Diagnostics, Inc, Decatur, IL). This device is commonly 
used in clinical practice for allergy skin testing. Animals were then exposed on each ear to 
25 μl of vehicle (DMSO) or 10% uITO for three consecutive days. Dosing suspensions were 
vortexed for ≈5 s before being withdrawn from the dosing vial for exposures. Animals were 
observed daily for systemic signs of toxicity (ruffled fur, abnormal posture, isolation in the 
cage, abnormal exudates from eyes, nose, anus) and for local signs of irritation including 
erythema and swelling. Animals were weighed the day prior to the first exposure and on 
Day 6 prior to euthanasia.
Modified local lymph node assay
To determine the potential for uITO to induce immune stimulation, local lymph node assays 
including modifications to routes of exposure were conducted following topical exposure via 
intact or breached skin or following intradermal injection. Given that there was concern for 
the potential of uITO to penetrate intact skin, the initial study consisted of dermal exposure 
on the dorsal surface of each ear (25 μl per ear) to groups of animals with either intact or 
breached skin. Breaching was accomplished using a Multi-Test II device as described above. 
To increase bioavailability, additional studies were conducted following 10 μl intradermal 
injections (using a 26-guage needle) of test article or PBS vehicle at the base of the ear pinna 
bilaterally. Based on the results of the toxicity study and the limits of uITO to go into 
suspension, dose response studies were conducted with concentrations of 2.5%, 5%, and 
10% (w/v) uITO. Five animals per group were used for all studies.
Following exposures, the LLNA was performed according to the method described in the 
Interagency Coordinating Committee on the Validation of Alternative Methods Peer Review 
Panel report (NIEHS, 2010) with minor modifications. Briefly, mice (five per group) were 
exposed to vehicle, increasing concentrations of uITO, or positive control (30% HCA, for 
intact dermal exposure study) for three consecutive days. Animals were allowed to rest for 2 
days following the last exposure. On Day 6, mice were injected intravenously via the lateral 
tail vein with 20 μCi [3H]-thymidine (specific activity 2 Ci/mmol; Dupont NEN, Boston, 
MA). Five hours after thymidine injection, mice were euthanized via CO2 asphyxiation, and 
the left and right cervical draining lymph nodes (DLN located at bifurcation of jugular vein) 
were excised and pooled for each animal. Single cell suspensions were made and incubated 
overnight in 5% trichloroacetic acid and samples were counted using a Packard Tri-Carb 
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2500TR liquid scintillation analyzer. Stimulation indices (SI) were calculated by dividing 
the mean disintegrations per minute (DPM) per test group by the mean DPM for the vehicle 
control group. EC3 values (concentration of chemical required to induce 3-fold increase 
over vehicle control) were calculated based on the equation from Basketter et al. (1999).
Phenotypic analysis of draining lymph node cells following intradermal exposure
To further evaluate the immune response to uITO exposure, phenotypic analysis of DLN 
was conducted using flow cytometry as previously described with minor modifications 
(Franko et al., 2012). Mice (10 per group) were injected intradermally with PBS or 5% uITO 
at the base of each ear (10 μl per ear) for three consecutive days. Five animals per group 
were allowed to rest for 2 days and euthanized by CO2 inhalation on Day 6 to coincide with 
the time course of the lymphocyte proliferation assay and the remaining five animals per 
group were allowed to rest for 7 days after the final exposure and then euthanized on Day 10 
by CO2 inhalation. Day 10 has previously been identified as the optimal day for the 
identification of IgE+/B220+ cells (Manetz & Meade, 1999). Draining lymph nodes were 
collected (left and right nodes/animal) in 2 ml PBS and dissociated using frosted ends of two 
microscope slides. Cell counts were performed using a Coulter Counter (Z2 model, 
Beckman Coulter, Fullerton, CA), and 106 cells/sample were added to wells of a 96-well 
plate. Cells were washed in PBS and then incubated with Live/Dead Fixable Far Red Dead 
Cell Stain (Life Technologies, Carlsbad, CA) in PBS for exclusion of non-viable cells. Cells 
were washed using flow staining buffer (1% bovine serum albumin/0.1% sodium azide in 
PBS) and then incubated with Fc block (clone 2.4G2). The cells were then incubated on ice 
in flow staining buffer with a combination of the following antibody conjugates: anti-
CD45R/B220 (V500 or Alexa Fluor 700, clone RA3-6B2, BD Biosciences, San Jose, CA), 
anti-CD3 (V500, clone 500A2, or APC, clone 145-2C11, BD), anti-CD4 (PE-Cy7, clone 
GK1.5, eBioscience, San Diego, CA), anti-CD8 (APC-H7 or PE, clone 53-6.7, BD), and 
anti-IgE (FITC, clone R35-72, BD). Cells were washed and fixed in cell fixation buffer 
(BD). For analysis, cells were re-suspended in staining buffer and analyzed on a BD 
Biosciences LSR II flow cytometer. All data were analyzed using FloJoe software. A 
minimum of 10 000 events per sample was collected.
Total serum IgE
Following euthanasia of animals used in the 10-day phenotypic analysis assay, blood 
samples were collected via cardiac puncture; sera were separated by centrifugation and 
frozen at –20 °C for subsequent analysis of serum IgE. A standard colorimetric sandwich 
ELISA was performed as previously described (Franko et al., 2012).
Statistical analysis
Data were first tested for homogeneity using the Barlett’s ChiSquare test. If homogeneous, a 
one-way analysis of variance (ANOVA) was conducted. If the ANOVA showed 
significance at p ≤ 0.05, the Dunnett’s Multiple Range t-test was used to compare treatment 
groups with the control group. For dose response studies, linear trend analysis was 
performed to determine if uITO had exposure concentration-related effects for specific end-
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points. Differences were considered to be significant if p+0.05 as compared to vehicle 
controls. A Student’s t-test was used when comparisons were made between two groups.
Results
Toxicity study
Exposure of breached skin to 10% uITO in DMSO produced no changes in body weight, 
systemic signs of toxicity, or visual signs of inflammation at the exposure sites (data not 
shown).
Lymphocyte proliferation following dermal exposure to uITO
A dose-responsive increase (Linear Trend Test; p<0.01) in proliferation was observed in 
animals exposed to increasing concentrations of uITO through both intact and breached skin 
(Figure 1). Similar levels of lymphocyte proliferation – as represented by [3H]-thymidine 
incorporation – were observed for the high dose groups (10% uITO) following exposure to 
intact and breached skin (2072 and 2036 dpm, respectively). However, the stimulation 
indices (SI) for these two exposures differed considerably with an SI of 5.7 following 
exposure to 10% uITO for the intact skin group and 1.8 for the breached skin group. The 
difference in SI following the two methods of dermal exposure can be explained by the 
increased proliferation observed following DMSO exposure to breached skin compared to 
intact skin (1134 vs 365 dpm, p<0.01). Using data from the intact exposure groups, the 
calculated EC3 value for uITO was 4.7%. The positive control group (HCA) had an SI of 
27, within the historical range for our laboratory (data not shown).
Lymphocyte proliferation following intradermal exposure to ITO
Given the variability in response between studies following dermal exposure, additional 
studies were conducted following intradermal administration of the test article in PBS to 
eliminate the DMSO effect and to increase bioavailability. A significant response (p<0.01) 
resulting in an SI of 6.1 was seen following exposure to 5% uITO, with no further increase 
in proliferation observed in the 10% dose group (Figure 2). No signs of systemic toxicity 
including body weight changes were observed in any of the mice in the study. There was a 
visibly noted dose-responsive erythema at the injection site, with no erythema in mice 
exposed to 2.5% uITO, a majority of mice exposed to the 5% dose demonstrating mild 
erythema, and mice exposed to a 10% level having mild-to-moderate erythema. In all cases, 
the erythema resolved by the day of euthanasia. At euthanasia, intradermal deposits of test 
article were visible in all mice exposed to any concentration of uITO.
Phenotypic analysis of draining lymph node cells and total serum IgE levels following 
intradermal exposure to uITO
Phenotypic analysis of draining lymph node cells was undertaken to begin to understand the 
mechanism of immune activation following exposure to uITO. Based on the results of the 
LLNA intradermal exposure study, a concentration of 5% uITO was chosen for this study. 
Consistent with lymphocyte proliferation data measured by incorporation of [3H]-thymidine, 
total cell numbers were significantly elevated (p<0.05) at the Day 6 timepoint (5.7 [±0.3] × 
106 for uITO-exposed vs 2.4 [±0.1] × 106 for VH-exposed animals). By Day 10, total cell 
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numbers increased (p<0.01), with counts reaching 14.0 [±1.8] × 106 in uITO mice compared 
to 3.5 [±0.7] × 106 for the vehicle hosts. Consistent with results from well characterized T-
cell-mediated sensitizers, at Day 10 an increase in absolute numbers (3.1 [±0.4] × 106 vs 0.5 
[±0.1] × 106; p<0.01) and percentage (23.3 [±0.9]% vs 12.5 [±0.9]%; p<0.01) of B220+ 
cells and a moderate increase in absolute numbers (p<0.01) with a decrease (p<0.05) in the 
percentage of both CD4+ (6.4 [±0.8] × 106 {48.4 [±0.7]%} vs 1.9 [±0.4] × 106 {55.1 
[±2.3]%}) and CD8+ (3.3 [±0.5] × 106 {24.8% ± 0.6%) vs 1.1 [±0.3] × 106 {29.7 [±1.2]%}) 
T-cells were observed in mice exposed to 5% uITO compared to in vehicle control 
counterparts. No significant increases in B220+/IgE+ cell absolute numbers/percentages or 
total serum IgE levels was noted (Table 2).
Discussion
Given the recent recognition of lung pathology associated with exposure and the lack of 
understanding of the pathophysiology of the disease process, these studies were undertaken 
to begin to investigate the potential immunomodulatory effects of ITO. A dermal model 
based on the LLNA was chosen to initiate the investigations based on the large LLNA 
database available for chemicals inducing both T-helper (TH)-1 and TH2 cell-mediated 
responses following this route of exposure and concern for the role of dermal exposure in 
development of the sensitization phase of several T-cell-(e.g., chronic beryllium disease; 
Tinkle et al., 2003; Cummings et al., 2007; Thomas et al., 2013) and IgE-(i.e., based on 
responses to latex (allergy); Woolhiser et al., 2000; Howell et al., 2002), acid anhydrides 
(Zhang et al. 2004), or isocyanates (Petsonk et al., 2000) mediated pulmonary diseases. 
Additionally, the easily isolated lymph node draining the ear provides a source of cells for 
mechanistic studies (Manetz & Meade, 1999).
Based on information provided by the supplier (Sigma), the uITO used in these studies was 
≤ 50 nm. Although reports on the potential for nanoparticles to penetrate the skin have been 
mixed (reviewed by Crosera et al., 2009), using a static in vitro diffusion system, Larese et 
al. (2009) demonstrated penetration of silver nanoparticles (ranging from 9.8–48.8 nm) 
through both intact and damaged full-thickness human skin. To simulate a more realistic 
workplace exposure paradigm, using an in vitro model with addition of mechanical flexion 
of the skin, Tinkle et al. (2003) demonstrated epidermal penetration of particles as large as 
1.0 μm. Penetration into the epidermal layer allows for Langerhans cells (skin antigen-
presenting cell) activation and immune activation. In these in vivo studies, using lymphocyte 
proliferation as a biomarker of exposure, data support a potential for uITO nanoparticles to 
penetrate both breached and intact skin.
Although animal studies investigating the potential for uITO to induce hypersensitivity 
responses have not previously been published, following pulmonary exposure to sintered 
ITO, toxicity studies have demonstrated hyperplasia of mediastinal lymph nodes with 
increased areas of lymphoid follicles and increased numbers of lymphocytes in mice 
(Nagano et al., 2011b) and the development of granulomas in bronchus-associated lymphoid 
tissue and mediastinal lymph nodes in rats (Nagano et al., 2011a,c). The cumulative results 
from the studies presented here support the potential for uITO to induce T-cell-mediated 
sensitization. Following dermal exposure to uITO, a dose-responsive increase in lymphocyte 
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proliferation was observed (reaching statistical significance and SI >3 at both 5% and 10% 
levels). The EC3 calculated for uITO was 4.7%, resulting in its classification as a mild 
sensitizer (Loveless et al., 2010). This classification is similar to other metals including 
nickel, which are known human sensitizers. Nickel chloride has been reported to have an 
EC3 of 3.5% (Basketter et al., 1994) and an EC3 of 2.5% has been reported for nickel 
sulfate (Ryan et al., 2002). Providing additional support for a TH1-mediated mechanism, 
phenotypic analysis of draining lymph node cells was consistent with that observed 
following exposure to well characterized T-cellmediated sensitizers with an increase in the 
%B220+ cells and a decrease in the %CD4+ and %CD8+ cells and no significant elevation in 
IgE+/B220+ cells (Manetz & Meade, 1999). This was further supported by absence of an 
elevation in total serum IgE in the uITO-exposed mice.
In addition to pulmonary alveolar proteinosis and other lung pathology, analysis of clinical, 
radiological, and histopathological data from cases of workers with indium lung disease 
revealed an increased cellularity of broncho-alveolar lavage fluid with a predominance of 
lymphocytes and the presence of granulomas associated with cholesterol clefts (Cummings 
et al., 2012). Previous findings in animal studies combined with these data demonstrating 
the potential for uITO to induce a T-cell mediated response in mice, raise concern for the 
potential for immunologically-mediated disease following occupational exposure to ITO. 
These studies provide further support for the need to better understand the natural history 
and pathophysiology of ITO mediated pulmonary disease.
References
Basketter DA, Lea LJ, Dickens A, et al. A comparison of statistical approaches to the derivation of 
EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 1999; 19:261–266. 
[PubMed: 10439340] 
Basketter DA, Scholes EW, Kimber I. The performance of the local lymph node assay with chemicals 
identified as contact allergens in the human maximization test. Food Chem. Toxicol. 1994; 32:543–
547. [PubMed: 8045461] 
Buüdinger L, Hertl M. Immunologic mechanisms in hyper-sensitivity reactions to metal ions: An 
overview. Allergy. 2000; 55:108–115. [PubMed: 10726725] 
Crosera M, Bovenzi M, Maina G, et al. Nanoparticle dermal absorption and toxicity: A review of the 
literature. Int. Arch. Occup. Environ. Health. 2009; 82:1043–1055. [PubMed: 19705142] 
Cummings KJ, Deubner DC, Day GA, et al. Enhanced preventive program at a beryllium oxide 
ceramics facility reduces beryllium sensitization among new workers. Occup. Environ. Med. 2007; 
64:134–140. [PubMed: 17043076] 
Cummings KJ, Donat WE, Ettensohn DB, et al. Pulmonary alveolar proteinosis in workers at indium 
processing facility. Am. J. Respir. Crit. Care Med. 2010; 181:458–464. [PubMed: 20019344] 
Cummings KJ, Nakano M, Omae K, et al. Indium lung disease. Chest. 2012; 141:1512–1521. 
[PubMed: 22207675] 
Franko J, Jackson LG, Hubbs AF, et al. Evaluation of furfuryl alcohol sensitization potential following 
dermal and pulmonary exposure: Enhancement of airway responsiveness. Toxicol. Sci. 2012; 
125:105–115. [PubMed: 22003193] 
Howell MD, Weissman DN, Jean Meade B. Latex sensitization by dermal exposure can lead to airway 
hyperreactivity. Int. Arch. Allergy Immunol. 2002; 128:204–211. [PubMed: 12119502] 
Larese FF, D’Agostin F, Crosera M, et al. Human skin penetration of silver nanoparticles through 
intact and damaged skin. Toxicology. 2009; 255:33–37. [PubMed: 18973786] 
Brock et al. Page 7
J Immunotoxicol. Author manuscript; available in PMC 2015 November 19.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Loveless SE, Api AM, Crevel RW, et al. Potency values from the local lymph node assay: Application 
to classification, labeling, and risk assessment. Regul. Toxicol. Pharmacol. 2010; 56:54–66. 
[PubMed: 19733604] 
Makrilia N, Syrigou E, Kaklamanos I, et al. Hypersensitivity reactions associated with platinum 
antineoplastic agents: A systematic review. Metal-Based Drugs. 2010; 1:1–11.
Manetz TS, Meade BJ. Development of a flow cytometry assay for the identification and 
differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T-cell-mediated 
hyper sensitivity responses. Toxicol. Sci. 1999; 48:206–217. [PubMed: 10353312] 
Nagano K, Gotoh K, Kasai T, et al. Two- and 13-week inhalation toxicities of indium-tin oxide and 
indium oxide in rats. J. Occup. Health. 2011a; 53:51–63. [PubMed: 21233592] 
Nagano K, Nishizawa T, Eitaki Y, et al. Pulmonary toxicity in mice by 2- and 13-week inhalation 
exposures to indium-tin oxide and indium oxide aerosols. J. Occup. Health. 2011b; 53:234–239. 
[PubMed: 21422720] 
Nagano K, Nishizawa T, Umeda Y, et al. Inhalation carcinogenicity and chronic toxicity of indium-tin 
oxide in rats and mice. J. Occup. Health. 2011c; 53:175–187. [PubMed: 21471693] 
NIEHS (National Institute of Environmental Health Sciences). ICCVAM (Interagency Coordinating 
Committee on the Validation of Alternative Methods) Test Method Evaluation Report on Using 
the Local Lymph Node Assay for Testing Pesticide Formulations, Metals, Substances in Aqueous 
Solutions, and Other Products: The results of an independent peer review evaluation coordinated 
by the ICCVAM and the NICEATM. 2010. NIH Publication No. 10–7512. Available online at: 
http://www.iccvam.niehs.nih.gov [last accessed 25 Apr 2013]
Nordberg, GF.; Fowler, BA.; Nordberg, M. Handbook on Toxicology of Metals. 3rd. Fridberg, L., 
editor. Academic Press; Burlington, MA: 2011. 
Petsonk EL, Wang ML, Lewis DM, et al. Asthma-like symptoms in wood product plant workers 
exposed to methylene diphenyl diisocyanate. Chest. 2000; 118:1183–1193. [PubMed: 11035694] 
POLINARES (EU Policy on Natural Resources). Fact sheet: Indium. 2012. Available from: http://
www.polinares.eu/docs/d21/polinares_wp2_annex2_factsheet5_v1_10.pdf [last accessed 20 Mar 
2013]
Ryan CA, Cruse LW, Skinner RA, et al. Examination of a vehicle for use with water-soluble materials 
in the murine local lymph node assay. Food Chem. Toxicol. 2002; 40:1719–1725. [PubMed: 
12176099] 
Thomas CA, Deubner DC, Stanton ML, et al. Long-term efficacy of a program to prevent beryllium 
disease. Am. J. Ind. Med. 2013; 56:733–741. [PubMed: 23450749] 
Tinkle SS, Antonini JM, Rich BA, et al. Skin as a route of exposure and sensitization in chronic 
beryllium disease. Environ. Health Perspect. 2003; 111:1202–1208. [PubMed: 12842774] 
USGS. United States Geological Survey. Mineral Commodity Summaries. 2013. U.S. Department of 
the Interior. Available from: minerals.usgs.gov/minerals/pubs/mcs/ [last accessed 20 Mar 2013]
Woolhiser MR, Munson AE, Meade BJ. Immunological responses of mice following administration of 
natural rubber latex proteins by different routes of exposure. Toxicol. Sci. 2000; 55:343–351. 
[PubMed: 10828266] 
Zhang XD, Fedan JS, Lewis DM, Siegel PD. Asthma-like biphasic airway responses in Brown Norway 
rats sensitized by dermal exposure to dry trimellitic anhydride powder. J. Allergy Clin. Immunol. 
2004; 113:320–326. [PubMed: 14767449] 
Brock et al. Page 8
J Immunotoxicol. Author manuscript; available in PMC 2015 November 19.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Lymphocyte proliferation. Proliferation was assessed by [3H]-thymidine incorporation into 
draining lymph node cells following dermal intact or breached skin exposure to vehicle 
(DMSO) or uITO. Bars represent means ± SE of five mice/group. Numbers appearing above 
the bars are the stimulation indices for respective concentration tested. Levels of statistical 
significance are denoted by *p<0.05 and **p<0.01 as compared to corresponding vehicle; 
#designates significant difference between animals exposed to DMSO or the same 
concentration of test article through breached vs intact skin. An EC3 of 4.7% was calculated 
for exposure to intact skin.
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Figure 2. 
Lymphocyte proliferation. Proliferation was assessed by [3H]-thymidine incorporation into 
draining lymph node cells following intradermal exposure to vehicle (PBS) or uITO. Bars 
represent means ± SE of five mice/group. Numbers appearing above the bars are the 
stimulation indices for respective concentration tested. Levels of statistical significance are 
denoted by *p<0.05 and **p<0.01 as compared to vehicle control.
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Table 1
Examples of known hypersensitivity responses to metals.
Metal
Hypersensitivity
response Associated disease
Platinuma Type I, Type IV Urticaria, Asthma
Nickelb Type IV Allergic contact dermatitis,
 Asthma
Cobaltc Type IV, Type I Allergic contact dermatitis,
 Asthma
Berylliumc Type IV, Type I Chronic beryllium disease
Chromiumc Type IV Allergic contact dermatitis
Goldc Types II, III, IV Allergic contact dermatitis,
 ‘burning mouth syndrome’
 in those with gold dental
 restorations, autoimmune
 thrombocytopenia
Palladiumc Type IV Allergic contact dermatitis
Mercuryc Type IV Allergic contact dermatitis
a
Makrilia et al. (2010);
b
Büdinger and Hertl (2000);
cNordberg et al. (2011).
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Table 2
Phenotypic and total serum IgE analysis.
Day 6 Day 10
End-point Vehicle 5% uITO Vehicle 5% uITO
Cell counts
 Total (×106 ) 2.4 ± 0.1 5.7 ± 0.3* 3.5 ± 0.7 14.0 ± 1.8**
 B220+ cells absolute
  (×106 ) (%)
0.3 ± 0.0
12.4 ± 1.0
1.1 ± 0.1*
19.0 ± 1.2*
0.5 ± 0.1
12.5 ± 0.9
3.1 ± 0.4**
23.3 ± 0.9**
 IgE+B220+ cells, % Not Tested Not Tested 4.6 ± 2.3 7.1 ±5.1
 CD4+ cells absolute
  (×106) (%)
1.4 ± 0.07
58.7 ± 0.6
2.9 ± 0.1*
50.4 ± 1.0*
1.9 ± 0.4
55.1 ± 2.3
6.4 ±0.8**
48.4 ±0.7*
 CD8+ cells absolute
  (×106) (%)
6.9 ± 0.4
29.1 ± 0.4
1.7 ± 0.0*
29.6 ± 0.3
1.1 ± 0.3
29.7 ± 1.2
3.3 ± 0.5**
24.8 ± 0.6*
 Total serum IgE
  (ng/ml)
Not Tested Not Tested 329 ± 94 394 ± 85
Values represent the mean ± SE from five animals per group. Statistical significance is designated as
*
p ≤ 0.05
**
p ≤0.01.
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